A mailed fecal immunochemical test for colorectal cancer screening, unrequested by the recipient, proved the best way to entice adults 45 to 49 years of age to undergo CRC screening, researchers from UCLA determined. In a randomized trial of 20,509 adults aimed to evaluate the best means of boosting CRC screening among this age group, which became eligible for screening in 2021 under guidelines set by the U.S. Preventive Services Task Force. Of the four strategies tested, the option found to be most acceptable was automatically being mailed a stool-based screening test, with no choice to “opt in” or “opt…
Author: Abhay Panchal
A new Annals of Internal Medicine study reports that hospitals acquired by private equity firms see sharp cuts in staffing and salaries — and a rise in emergency department deaths and patient transfers. Earlier analyses show higher infection rates, more adverse events, and higher costs across private-equity-owned facilities, with no consistent improvements in care. Frontline physicians warn profit-first staffing models are replacing physician-led groups with cheaper labor, jeopardizing patient safety and accelerating burnout. Advocacy groups, including Take Medicine Back and the Association for Independent Medicine, are now pushing state-level action to restore physician control and enforce corporate practice of medicine…
The World Health Organization has issued first-of-its-kind guidance recognizing obesity as a chronic, relapsing disease requiring lifelong care — and endorsing GLP-1 therapies as part of long-term treatment for adults with obesity. With 1+ billion people affected and 3.7 million deaths in 2024, the WHO says medication-supported care could dramatically reduce cardiometabolic and cancer risks — but warns of rising costs, limited long-term data, and widening access gaps. Even by 2030, fewer than 10% of eligible patients may receive GLP-1 treatment. The new guidelines call for:• GLP-1 therapies paired with structured nutrition & activity programs• Earlier screening and chronic-care follow-up•…
Washington University and Emory researchers have secured nearly $3.2M from the Helmsley Charitable Trust to tackle one of IBD’s toughest challenges: perianal fistulizing Crohn’s disease, which affects up to 40% of patients and remains notoriously difficult to treat. The 3-year project will develop AI and deep-learning tools to interpret MRI scans, define fistula healing more precisely, and predict which patients will respond to therapy — paving the way for more personalized and effective care.
Three powerhouse GI platforms continue to dominate physician-practice acquisitions and ASC expansion nationwide: GI Alliance (TX) ~1,000 physicians | 400+ sites | 20 statesNow partially owned by Cardinal Health ($2.8B deal in 2024), GI Alliance is accelerating outpatient expansion with new ASCs in Missouri and Arkansas and partnerships to boost admin efficiency and GI clinical trial access. Gastro Health (FL) 400+ physicians | 150+ locationsBacked by OMERS Private Equity, Gastro Health is leaning heavily on ASC-focused JV strategy in major metro markets and recently strengthened its clinical leadership team to fuel growth. United Digestive (GA) 129 physicians | 80+ sitesPowered…
Swan EndoSurgical has named longtime Stryker executive Erik Todd as CEO, signaling a major push to commercialize its flexible endoluminal surgical robotics platform. Backed by Revival Healthcare Capital and Olympus, the company aims to reshape advanced GI intervention with fully integrated robotic technology — targeting procedures that today remain complex, invasive, and costly. Todd’s arrival brings 25+ years of robotics leadership as Swan prepares for its next scale phase.
University of Miami researchers report that a customized large language model achieved ~95% accuracy in recommending guideline-based follow-up colonoscopy intervals — matching GI physicians in most cases. The tool, validated in 1,000 patient colonoscopy datasets and published in AJG, could reduce errors and save clinicians time, though experts stress a human-in-the-loop remains essential as hallucination and complex cases still challenge current models.
November was a pivotal month in gastroenterology, marked by the first-ever FDA-approved treatment for pediatric IBS-C, updated AGA guidelines pushing for early use of high-efficacy therapies in Crohn’s disease, and new safety data supporting that shift. Yet progress brought new pressure points: research highlighted worsening geographic disparities in GI access, and AI tools—despite hype—failed to meet clinical standards for IBS dietary guidance, reinforcing the continued need for human expertise in digestive care.
A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and tumor locations. METHODOLOGY:
The Dietitians in Gastrointestinal Disorders (DIGID), a practice group within Dietitians in Medical Nutrition Therapy (DMNT) of the Academy of Nutrition and Dietetics, have announced the launch of the Board Certified Specialist in Digestive Health (CSDH) credential, now available through the Commission on Dietetic Registration (CDR). This new specialty certification recognizes registered dietitians with advanced training and experience in digestive health and gastrointestinal (GI) diseases.